SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-18-014234
Filing Date
2018-12-21
Accepted
2018-12-21 17:07:27
Documents
2
Period of Report
2018-12-20

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 5149
2 ex24glickman.txt EX-24 3896
  Complete submission text file 0001179110-18-014234.txt   10460
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Issuer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 640 LEE ROAD CHESTERBROOK PA 19087
Business Address
Glickman Mark A (Reporting) CIK: 0001441461 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35986 | Film No.: 181250414